Arylacetamide deacetylase (EC 3.1.1.3)
1_MGRKS 6_ LYLLI 11_ VGILI 16_ AYYIY 21_ TPLPD 26_ NVEEP 31_ WRMMW 36_ INAHL 41_ KTIQN 46_ LATFV 51_ ELLGL 56_ HHFMD 61_ SFKVV 66_ GSFDE 71_ VPPTS 76_ DENVT 81_ VTETK 86_ FNNIL 91_ VRVYV 96_ PKRKS 101_ EALRR 106_ GLFYI 111_ HGGGW 116_ CVGSA 121_ ALSGY 126_ DLLSR 131_ WTADR 136_ LDAVV 141_ VSTNY 146_ RLAPK 151_ YHFPI 156_ QFEDV 161_ YNALR 166_ WFLRK 171_ KVLAK 176_ YGVNP 181_ ERIGI 186_ SGDSA 191_ GGNLA 196_ AAVTQ 201_ QLLDD 206_ PDVKI 211_ KLKIQ 216_ SLIYP 221_ ALQPL 226_ DVDLP 231_ SYQEN 236_ SNFLF 241_ LSKSL 246_ MVRFW 251_ SEYFT 256_ TDRSL 261_ EKAML 266_ SRQHV 271_ PVESS 276_ HLFKF 281_ VNWSS 286_ LLPER 291_ FIKGH 296_ VYNNP 301_ NYGSS 306_ ELAKK 311_ YPGFL 316_ DVRAA 321_ PLLAD 326_ DNKLR 331_ GLPLT 336_ YVITC 341_ QYDLL 346_ RDDGL 351_ MYVTR 356_ LRNTG 361_ VQVTH 366_ NHVED 371_ GFHGA 376_ FSFLG 381_ LKISH 386_ RLINQ 391_YIEWL
1: Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity